Lapatinib and Obatoclax Kill Breast Cancer Cells Through Reactive Oxygen Species-dependent Endoplasmic Reticulum Stress

Overview

Journal Mol Pharmacol

Specialties Molecular Biology
Pharmacology

Date 2012 Sep 20

PMID 22989520

Citations 28

Authors

Nichola Cruickshanks

Yong Tang

Laurence Booth

Hossein Hamed

Steven Grant

Paul Dent

Affiliations

Soon will be listed here.

Abstract

Previous studies showed that lapatinib and obatoclax interact in a greater-than-additive fashion to cause cell death and do so through a toxic form of autophagy. The present studies sought to extend our analyses. Lapatinib and obatoclax killed multiple tumor cell types, and cells lacking phosphatase and tensin homolog (PTEN) function were relatively resistant to drug combination lethality; expression of PTEN in PTEN-null breast cancer cells restored drug sensitivity. Coadministration of lapatinib with obatoclax elicited autophagic cell death that was attributable to the actions of mitochondrial reactive oxygen species. Wild-type cells but not mitochondria-deficient rho-zero cells were radiosensitized by lapatinib and obatoclax treatment. Activation of p38 mitogen-activated protein kinase (MAPK) and c-Jun NH(2)-terminal kinase 1/2 (JNK1/2) by the drug combination was enhanced by radiation, and signaling by p38 MAPK and JNK1/2 promoted cell killing. In immunohistochemical analyses, the autophagosome protein p62 was determined to be associated with protein kinase-like endoplasmic reticulum kinase (PERK) and inositol-requiring enzyme 1, as well as with binding immunoglobulin protein/78-kDa glucose-regulated protein, in drug combination-treated cells. Knockdown of PERK suppressed drug-induced autophagy and protected tumor cells from the drug combination. Knockdown of PERK suppressed the reduction in Mcl-1 expression after drug combination exposure, and overexpression of Mcl-1 protected cells. Our data indicate that mitochondrial function plays an essential role in cell killing by lapatinib and obatoclax, as well as radiosensitization by this drug combination.

Citing Articles

Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer.

Lin W, Wang X, Diao M, Wang Y, Zhao R, Chen J Cancer Cell Int. 2024; 24(1):239.

PMID: 38982494 PMC: 11234736. DOI: 10.1186/s12935-024-03418-x.

Longitudinal drug synergy assessment using convolutional neural network image-decoding of glioblastoma single-spheroid cultures.

Giczewska A, Pastuszak K, Houweling M, Abdul K, Faaij N, Wedekind L Neurooncol Adv. 2023; 5(1):vdad134.

PMID: 38047207 PMC: 10691443. DOI: 10.1093/noajnl/vdad134.

ER stress as a trigger of UPR and ER-phagy in cancer growth and spread.

Cherubini A, Zito E Front Oncol. 2022; 12:997235.

PMID: 36408145 PMC: 9667062. DOI: 10.3389/fonc.2022.997235.

Eupalinolide B inhibits hepatic carcinoma by inducing ferroptosis and ROS-ER-JNK pathway.

Zhang Y, Zhang H, Mu J, Han M, Cao Z, Dong F Acta Biochim Biophys Sin (Shanghai). 2022; 54(7):974-986.

PMID: 35866605 PMC: 9827796. DOI: 10.3724/abbs.2022082.

Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy.

Hu T, Hou W, Xiao E, Long M Genes Dis. 2022; 9(3):659-667.

PMID: 35782985 PMC: 9243343. DOI: 10.1016/j.gendis.2021.02.005.

References

Martin A, Mitchell C, Rahmani M, Nephew K, Grant S, Dent P . Inhibition of MCL-1 enhances lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy. Cancer Biol Ther. 2009; 8(21):2084-96. PMC: 3887451. DOI: 10.4161/cbt.8.21.9895. View

Hynes N, Lane H . ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005; 5(5):341-54. DOI: 10.1038/nrc1609. View

Tao R, Maruyama I . All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J Cell Sci. 2008; 121(Pt 19):3207-17. DOI: 10.1242/jcs.033399. View

Ware K, Marshall M, Heasley L, Marek L, Hinz T, Hercule P . Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression. PLoS One. 2010; 5(11):e14117. PMC: 2994708. DOI: 10.1371/journal.pone.0014117. View

Cruickshanks N, Hamed H, Bareford M, Poklepovic A, Fisher P, Grant S . Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XL and MCL-1. Mol Pharmacol. 2012; 81(5):748-58. PMC: 3336802. DOI: 10.1124/mol.112.077586. View

Pattingre S, Espert L, Biard-Piechaczyk M, Codogno P . Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie. 2007; 90(2):313-23. DOI: 10.1016/j.biochi.2007.08.014. View

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

Rahmani M, Davis E, Crabtree T, Habibi J, Nguyen T, Dent P . The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress. Mol Cell Biol. 2007; 27(15):5499-513. PMC: 1952105. DOI: 10.1128/MCB.01080-06. View

Geyer C, Forster J, Lindquist D, Chan S, Romieu C, Pienkowski T . Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med. 2006; 355(26):2733-43. DOI: 10.1056/NEJMoa064320. View

10.

Ni Chonghaile T, Letai A . Mimicking the BH3 domain to kill cancer cells. Oncogene. 2009; 27 Suppl 1:S149-57. PMC: 3733265. DOI: 10.1038/onc.2009.52. View

11.

Kong A, Calleja V, Leboucher P, Harris A, Parker P, Larijani B . HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells. PLoS One. 2008; 3(8):e2881. PMC: 2483931. DOI: 10.1371/journal.pone.0002881. View

12.

Mitchell C, Yacoub A, Hossein H, Martin A, Bareford M, Eulitt P . Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo. Cancer Biol Ther. 2010; 10(9):903-17. PMC: 3040858. DOI: 10.4161/cbt.10.9.13273. View

13.

Yoon J, Ahn S, Lee B, Jung S, Oh S . Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. Biochem Pharmacol. 2012; 83(6):747-57. DOI: 10.1016/j.bcp.2011.12.029. View

14.

Tang Y, Hamed H, Cruickshanks N, Fisher P, Grant S, Dent P . Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. Mol Pharmacol. 2012; 81(4):527-40. PMC: 3310419. DOI: 10.1124/mol.111.076851. View

15.

Jia W, Loria R, Park M, Yacoub A, Dent P, Graf M . The neuro-steroid, 5-androstene 3β,17α diol; induces endoplasmic reticulum stress and autophagy through PERK/eIF2α signaling in malignant glioma cells and transformed fibroblasts. Int J Biochem Cell Biol. 2010; 42(12):2019-29. DOI: 10.1016/j.biocel.2010.09.003. View

16.

Seminario M, Precht P, Wersto R, Gorospe M, Wange R . PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression. Oncogene. 2003; 22(50):8195-204. DOI: 10.1038/sj.onc.1206872. View

17.

Rahmani M, Davis E, Bauer C, Dent P, Grant S . Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. J Biol Chem. 2005; 280(42):35217-27. DOI: 10.1074/jbc.M506551200. View

18.

van Delft M, Huang D . How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res. 2006; 16(2):203-13. DOI: 10.1038/sj.cr.7310028. View

19.

Taskar K, Rudraraju V, Mittapalli R, Samala R, Thorsheim H, Lockman J . Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer. Pharm Res. 2011; 29(3):770-81. PMC: 3489161. DOI: 10.1007/s11095-011-0601-8. View

20.

Gewirtz D . Autophagy as a mechanism of radiation sensitization in breast tumor cells. Autophagy. 2007; 3(3):249-50. DOI: 10.4161/auto.3723. View